Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$2.3 - $6.29 $811 - $2,220
-353 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$4.63 - $9.94 $1,634 - $3,508
353 New
353 $2,000
Q4 2021

Jan 25, 2022

SELL
$8.35 - $12.6 $50,333 - $75,952
-6,028 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$13.27 - $18.48 $21,935 - $30,547
1,653 Added 37.78%
6,028 $94,000
Q1 2021

Apr 30, 2021

BUY
$14.49 - $20.72 $16,301 - $23,310
1,125 Added 34.62%
4,375 $71,000
Q4 2020

Feb 11, 2021

BUY
$14.61 - $22.14 $29,220 - $44,280
2,000 Added 160.0%
3,250 $69,000
Q3 2020

Nov 03, 2020

BUY
$13.67 - $17.77 $17,087 - $22,212
1,250 New
1,250 $19,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $184M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.